Skip to main content
letter
. 2023 Feb 23;7(3):e847. doi: 10.1097/HS9.0000000000000847

Figure 1.

Figure 1.

Survival analysis of CMML patients with SIAD according to CPSS and CPSS-mol risk score. (A) OS and (B) PFS of patients with SIAD according to the CPSS risk score. Distribution of patients in the different groups of the CPSS risk score: 7 high, 15 intermediate-2, 13 intermediate-1, and 11 low. (C) OS and (D) PFS of patients with SIAD according to the CPSS-Mol risk score. Distribution of patients in the different groups of the CPSS-Mol risk score: 26 high, 11 intermediate-2, 6 intermediate-1, and 2 low. Survival curves were compared with the log-rank test. CPSS = CMML-Specific Prognostic Scoring System; OS = overall survival; PFS = progression-free survival; SIAD = systemic inflammation and autoimmune disorders.